1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SMART PILL MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Diagnostic Smart Pills
5.3. Therapeutic Smart Pills
5.4. Monitoring Smart Pills
6. SMART PILL MARKET BY TARGET TYPE
6.1. Introduction
6.2. Gastrointestinal Disorders
6.3. Oncology
6.4. Cardiovascular Diseases
6.5. Neurological Disorders
6.6. Infectious Diseases
6.7. Others
7. SMART PILL MARKET BY APPLICATION
7.1. Introduction
7.2. Capsule Endoscopy
7.3. Drug Delivery
7.4. Patient Monitoring
8. SMART PILL MARKET BY END-USERS
8.1. Introduction
8.2. Hospital and Clinics
8.3. Ambulatory Surgical Centers
8.4. Home Healthcare Settings
8.5. Diagnostic Laboratories
9. SMART PILL MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Medtronic
11.2. Proteus Digital Health
11.3. Rani Therapeutics
11.4. Medimetrics S.A. de C.V.
11.5. Otsuka America Pharmaceutical, Inc.
11.6. CapsoVision Inc.
11.7. Koninklijke Philips N.V.
11.8. Olympus Corporation
11.9. Bio-Images Research Limited
11.10. Novartis AG
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations